Search

everythinglearnresearchcommunity

for

Search:↓

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

About 61% of women who had COVID-19 experienced hair loss afterward.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

COVID-19 may cause hair loss by affecting hair follicles.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 can cause temporary hair loss.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

COVID-19 can cause hair and nail disorders after infection.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 pneumonia may cause lasting lung damage like fibrosis.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.